Supplementary Data from Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine Versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined